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ABSTRACT 
Neiserria meningitidis remains an important cause of morbidity 
and mortality in South Africa (SA). It is the sixth commonest 
c ause of notified disease with a case fatality rate of 11% for 
t he period 1990 1994. Identification of preventable risk 
f actors is critical as no effective vaccine exists for serogroup 
B, the most prevalent serogroup in SA. 
A case control study was undertaken to determine the risk factors 
associated with meningococcal disease. The study population 
consisted of all children under the age of 14 years who were 
re sidents of the Cape Town City Council and Cape Metropolitan 
Council areas of jurisdiction. Cases were identified from weekly 
notification reports and from admissions to the City Hospital for 
I nfectious Diseases. Controls were selected from the trauma wards 
at Red Cross War Memorial Childrens Hospital. Data was analyzed 
u sing EPI INFO and SAS statistical software. 
During the period October 1993 to January 1995 70 cases and 210 
controls were interviewed. Cases were significantly younger than 
controls (p = 0.0001). On univariate analysis significant risk 
f actors for meningococcal disease included: a household where 
2 or more members smoked (odds ratio (OR) =1.8), recent upper 
r espiratory tract infection (OR= 1.8), poor nutritional status 
(OR= 3.6), being breastfed for less than 3 months (OR= 2.7) and 
overcrowding (OR= 2.8). 
ll 
After adjusting for confounders the main force of passive smoking 
as a risk factor for meningococcal disease appeared to be in the 
presence of a recent upper respiratory tract infection. Other 
factors that remained significant after adjusting for confounders 
included: being breastfed for less than three months (adjusted 
OR= 2.4) and being less than 4 years old (adjusted OR= 2.3). 
This is the first case control study in South Africa examining 
risk factors associated with meningococcal disease. The study 
provides further evidence for the reduction of smoking, reduction 
of overcrowding and the promotion of breast-feeding as important 
public health measures. It also identifies children under the age 
of 4 years as an important target group should an effective 
vaccine become available. 
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PASSIVE SMOKING AND MENINGOCOCCAL DISEASE 
INTRODUCTION 
Neisseria meningitidis is an important cause of morbidity and 
mortality in South Africa(SA) . Meningococcal infection , a 
notifiable disease in SA since 1945, is the sixth commonest cause 
of notified disease and the second commonest cause of notified 
mortality in South Africa1 • A review of the notification reports 
for the past ten years revealed that children under five years 
are the most severely affected, the case fatality ratio remains 
high and the highest incidence by region has been in the Western 
Cape2 · 7 _ The incidence in the Western Cape for the period 1983 -
1988 was consistently more than twice that for any other region 
in SA5 . Geographical analysis of the notifications of the W.Cape 
for 1988 revealed the disease to be widespread with certain 
magisterial districts viz. Vredenberg, Prince Albert, Wal vis Bay, 
Malmesbury, and Cape Town having a very high incidence 4 • In SA 
meningococcal disease has a cyclic seasonal occurrence with most 
cases occurring during winter and early spring8 • There is a 
pressing need to identify and develop avenues for primary 
prevention of meningococcal disease in children. 
The majority of infections in South Africa (SA) are due to 
serogroup B9 - 11 . This serogroup has a relatively non - immunogenic 
polysaccharide capsule . Several outer membrane protein based 
serogroup B meningococcal vaccines have been developed and 
evaluated, but a highly immunogenic vaccine for children under 
2 





In the absence of an effective vaccine identification, prevention 
and elimination of risk factors is one possible way of decreasing 
the incidence. Factors implicated as determinants of 
meningococcal disease are; complement
10
-
30 and immunoglobulin 










s o cioeconomic status41 - 44 , contact with a case of meningococcal 









Passive smoking is now known to be a risk factor for acute 
respiratory infections47 - 51 and acute otitis media in children
5 2
• 
Several studies have shown that the smoking prevalence in South 
Africa is high53 - 58 • If passive smoking does increase the risk of 
meningococcal disease, this is then yet another reason to 
r ecommend a reduction in exposure to cigarette smoke as an 
i mportant public health measure. The identification of other 
potential risk factors is also important in the primary 
p revention of meningococcal disease and in identifying target 
g r oups should an effective vaccine become available. 
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AIM 
The aim of this study was to determine the association between 
exposure to tobacco smoke (passive) and meningococcal disease in 
c hildren. 
OBJECTIVES 
1. To determine the degree of exposure to tobacco smoke in cases 
and controls. 
2 . To measure potential confounding and other exposure variables 
of interest in cases and controls. 
These included: 
a. Degree of household crowding 
b. Type of dwelling 
c. Attendance at a creche 
d. Duration of breast feeding 
e. Contact with a case 
f. Nutritional status 
g. Recent antibiotic usage 
h. Recent upper respiratory tract infection 
3. To determine the effect of smoking on meningococcal disease 
a f ter adjusting for confounders. 
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4. LITERATURE REVIEW 
4.1 Microbiology 
Meningococcal meningitis was first described by Gaspard Viesseux 
i n Geneva in 1805 59 • The organism, a Gram-negative diplococcus, 
was first isolated from cerebrospinal fluid in 1887 by 
Weischbaum6 0 . The meningococcus is classified on the basis of its 
po lysaccharides, outer membrane proteins (OMPs) and 
l i popolysaccharides. Capsular polysaccharides are classified into 
12 serogroups: A, B, C, X, Y, Z, Wl35, 29E (Z'), H, I, Kand L61 • 
Unique serotypes are defined on the basis of antigenic 
differences in the Class 2 and 3 OMPs while differences in the 
Class 1 OMPs determine subtypes 62 • 6 3 • There are currently 20 
s ero t ypes and at least 10 class 1 subtypes 64 • 
4.2 Global Epidemiology 
Of the 12 serogroups most illness is caused by serogroups A, B, 
a nd C. Epidemic group A meningococcal disease has been documented 
i n various parts of the developing world. Outbreaks begin during 
the dry season and end with the onset of the rainy season. Attack 
r a tes generally range from 100 to 500 per 100 000 39 • Periodic 
outbreaks occur in sub- Saharan Africa in an area now named the 
meningitis belt of Africa. The borders of the belt were initially 
de scribed by Lapeyssonnie 3 7 and later extended by Greenwood38 • 
Al though it was initially thought that epidemics occurred in 
5 
p r edictable cycles in the belt, it has now been established that 
cyclical patterns are not present in most countries included in 
the meningitis belt 64 • 
Group B meningococci are the major cause of sporadic disease in 
developed countries 6 5 • 66 • During the 1970s a group B clone was 
responsible for outbreaks in Norway, Denmark, the Netherlands and 
Great Britain67 • Spread of this clone was later documented in 
Cuba, Chile, Rio de Janeiro and Sao Paulo68 • The majority of 
infections in South Africa (SA ) are due to serogroup B9 - 11 • 
Group C meningococci have been implicated in large outbreaks 69 , 
small disease clusters 7 0 and sporadic infections. During the 
1980 s the proportion of sporadic disease caused by the Group C 
organisms increased in several European countries; a single 
s t rain was responsible for most of this increase71 • 
4.3 Clinical Picture 
Infection with the meningococcus results in one of four major 
cl inical condi tions 6 4 • 
1 . Meningitis 
This is the most common pathological presentation. Patients 
present with the classical signs of fever, headache, a stiff neck 
a nd frequently a petechial rash. Mortality, despite antimicrobial 
treatment and supportive care remains, at about 5 % in children 
younger than 5 years of age and between 10 to 15% in adults 6 4 • 
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2. Meningococcaemia 
This is the most severe form of the disease. Patients may present 
with a petechial or purpuric rash, hypotension, disseminated 
intravascular coagulation and/or multi-organ failure. The case 
fatality rate ranges from 15 to 30%. Poor prognostic signs 
inc lude shock, coma, seizures, disseminated intravascular 
coagulation and thrombocytopenia72 • 
3. Metastatic manifestations 
These can include arthritis, pericarditis and endophthalmitis. 
4. Asymptomatic nasopharyngeal carriage 
This is the most common of the clinical conditions. The upper 
respiratory tract of humans is the only reservoir of N 
meningitidis and asymptomatic 
considered the usual source of 
nasopharyngeal carriers are 
infection. The prevalence of 
meningococci in asymptomatic carriers has been the subject of 
numerous studies in civilian and military populations73 - 79 • Factors 
associated with carriage include age (15- 24 years) 77 , male 77 , 
active smoking77 • 8 0 - 82 , ABO secretor status81 and passive cigarette 
smoking77 • 83 • It is postulated that cigarette smoke interferes with 
ciliary action and this may predispose to the colonisation of the 
pharynx with N meningi tidis80 • 
and carriage could account 
The association between smoking 
for the increased risk of 
meningococcal disease in those who live with smokers and in 
chi ldren who live with a smoker35 ' 46 • Studies have also examined 
the relation between the incidence of meningococcal disease and 
meningococcal carriage78 • 84 • 85 • The pressing needs of the military 
7 
situation in the first World War brought about a number of 
carrier studies. The World War one concept had it that prior to 
an outbreak of meningococcal disease carriers rose from a 
normal of 2 - 4 % to 20 - 30%. Twenty percent was regarded as the 
danger point beyond which epidemics occurred. However the 
li terature does not clearly bring out the facts on which this was 
based. Furthermore in spite of great care to detect and eliminate 
carr i ers the meningococcal incidence in troops were still much 
greater than in the civilian population84 • In addition studies 
done on meningococcal carriage and disease from 1941 1945 
s howed that the incidence of disease was seasonal whilst the 
carriage rate remained constant 84 • In 1950 Agcock and Muller 
e stablished that the incidence of illness did not appear to be 
a function of the percentage of carriers. This observation was 
corroborated by Wenzel et al 85 (1973). It is now believed that 
additional factors are important determinants of disease. 
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4.4 Risk Factors for Meningococcal Disease 
4.4.1 Host Factors 
Individual host factors that predispose to invasive meningococcal 
disease have been well described. These include: age, complement 
deficiency, immunoglobulin deficiency, preceding upper 
respiratory infections and stress. 
Age 
The risk of meningococcal disease decreases with increasing age. 
In a surveillance project in the United States, 49% of invasive 
meningococcal disease occurred in those under the age of two 
years 86 • A high incidence of meningococcal disease in childhood, 
with a peak in the first year of life has been reported in many 
studies11 • 87 • 41 • This could be related to the lack of specific anti-
meningococcal antibodies at this age. 
Complement and Immunoglobulin Deficiencies 
Deficiencies in the complement E>ystem18 • 19 , particularly the 
terminal components ( CS to CB) 20 - 24 , are known to predispose to 
meningococcal disease. Recently disease has been described in 
persons with deficiencies of C2 25 , C3 21 , homozygous C4b2 6 
and C9 27 • 28 • Persons with compliment deficiency have a lower case 
fatality rate than the overall case fatality rate for 
meningococcal disease. 
9 
Absent or dysfunctional properdin has also been shown to increase 
t he risk of disease 29 • 30 • Properdin deficiency is associated with 
a higher case fatality rate compared to patients with terminal 
component complement deficiency30 • 
Reports have found an association between IgM deficiency
31 and 
I gG2 32 subclass deficiency and meningococcal disease. 
Upper Respiratory Tract Infection 
The condition of the host pharyngeal mucosa may also be important 
in protecting against invasive disease. 
influenza type A and meningococcal 






Recent studies have suggested an association between stress and 
meningococcal disease 35 • 36 • 
4.4.2 Environment 
Climate 
The peculiar borders of the African meningitis belt have prompted 
studies of the role of climate as a factor in epidemics. 
Wi thin the meningitis belt the greatest incidence of disease is 
in the dry season37 • 38 • However dry seasons can pass without 
10 
epidemics. In the Western Cape meningococcal disease is seasonal 
with the majority of cases occurring in the wet winter months
8
• 
The role of climatic factors in precipitating outbreaks remains 
unclear. 
Crowding 
The role of crowding in the pathogenesis of meningococcal disease 
is controversial. Studies undertaken by Glover in barracks in the 
First World War40 and by Stanwell - Smith et al 36 in England in 
1988 suggested that overcrowding was associated with disease. 
However Stuart et al 46 and Greenwood BM et al 4 4 found that 
overcrowding was not associated with meningococcal disease. 
Social Class 
An association between lower social class, poverty and 
meningococcal disease has been demonstrated in the United States 
o f America41 and in Europe4 2 • 43 • However this association was not 
found in a study in Africa44 • The authors of the African study 
postulated that in the villages studied, inhabitants lived at 
a socio-economic level below which this factor begins to 
influence susceptibility to disease. 
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Passive Smoking 
Recent studies have suggested an association between passive 
smoking and meningococcal disease35 • 3 6 • 39 • 46 • In the study by 
Stanwell-Smith et al 36 , the odds ratios for disease in children 
under the age of five years increased both with the number of 
cigarettes smoked and with the number of smokers in the 
household, suggesting a dose-response relationship. Active 
smoking has been shown to be associated with increased carriage 
of the meningococcus 82 • 83 • 85 • Thus children living in homes with 
smokers have higher exposure rates to meningococci and could thus 
have a greater chance of acquiring disease. 
4.4.3 Organism 
As discussed earlier different serogroups are responsible for 
different patterns of meningococcal disease. Strain 
characteristics also affect the pattern of disease. Some strains 
of meningococcal serogroups are more associated with epidemics 
than others. Olyhoek et al used isoenzyme electrophoresis and 
monoclonal typing to distinguish clonal populations in a large 
series of Group A meningococcal isolates from 28 different 
epidemics88 . In all but one epidemic, a single clonal population 
was responsible for disease. 
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4.5 Prevention 
4.5.1 Primary Prevention - Vaccine 
Efforts to develop a successful vaccine against meningococcal 
disease began in the early 1900s37 • Today vaccines are available 
against four meningococcal serogroups viz serogroups A, C, Y and 
Wl35 39 • 89 • Currently no effective vaccine against serogroup B is 
available and unfortunately the majority of infections in SA are 
due to serogroup B9 - 11 • 
Serogroup B has a relatively non - immunogenic polysaccharide 
capsule . Several outer membrane protein based serogroup B 





However the only two vaccines that have demonstrated some 
protective efficacy have been a Norwegian and a Cuban developed 
vaccine . 
The Norwegian vaccine was assessed in a placebo - controlled, 
randomised double blinded trial among children aged 12 to 16 
years in Norway14 • The estimated vaccine efficacy was 57% (lower 
confidence interval= 27%). On this basis the vaccine was not 
considered sufficiently efficacious to be considered for general 
use. 
The Cuban vaccine was initially tested in children aged 10 to 16 
years and was reported to have a vaccine efficacy (VE) of 81% in 
this age group15 • Although the Cuban trial did not address VE in 
13 
children under the age of 10 years, over 850 000 Cuban children 
aged less than 6 have been vaccinated and the VE in this younger 
age group was estimated, based on vaccine coverage and incidence 
of meningococcal disease, to be 93%. 
Two studies have been conducted in Brazil to test the VE of the 
Cuban vaccine1 6 • 17 • The Sao Paulo study found the VE varied by 
age in children older than 4 years of age VE was 74%, (95% CI 
1 6% -92%), in those aged 24 to 47 months VE was 47% (95% CI -72% 
to 84 %) and in those under the age of 24 months VE was - 37% 
(9 5% CI less than - 100% to 73%)
1 6
• 
The second study conducted in Rio de Janeiro, Brazil in 1990 in 
children aged 6 months to 9 years showed that the VE was 54% 
(95% CI 20% - 74% ) 17 • VE also varied by age being 71% in children 
4 years and older (95% CI 34% - 87%) , 14% in children 24 - 47 
months ( 95% CI - 165% to 72%) and 41 % in children 6 - 23 months 
( 95% CI - 96% to 82 %) Despite the potential value in older 
children the public health impact has been disappointing - rates 
o f disease have not changed much before and after the vaccine 
c ampaign in Sao Paulo16 • 
The results from both studies suggest that the while the Cuban 
p roduced vaccine may be effective in older children it has a low 




- the age 
g roup most seriously affected by serogroup B. Development of an 
e ffective group B vaccine remains a high priority for reducing 
d isease 
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4.5.2 Secondary Prevention 
Current recommendations of the Advisory Committee on Immunization 
Pr actices are that household members, day-care centre contacts 
and persons exposed to the oral secretions of the patient should 
r eceive prophylaxis90 • The antibiotic of choice is rifampicin 
(6 00mg every 12 hours for adults for 2 days, lOmg/kg every 12 
hours for 2 days for children one month and older and 5mg/kg 
every 12 hours for 2 days for children less than a month old). 
4.6 Treatment 
Serum therapy was the first successful treatment of meningococcal 
di sease91 • The discovery of sulfa in the 1930s and its success in 
treating meningococcal disease was a major advance and replaced 
s e rum therapy as the treatment of choice. When sulfa resistance 
developed,in the 1950s, penicillin became the treatment of 
choice. Penicillin resistant strains have however been reported 
from various countries92 - 95 • Disease associated with these strains 
has a higher mortality rate
95
• Chloramphenicol is an alternative 
to penicillin for the treatment of meningococcal disease. 
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5. METHODS 
5.1 STUDY DESIGN AND POPULATION 
A case-control study was conducted between October 1993 and 
January 1995. The study population consisted of all children 
under the age of fourteen years who were permanent residents of 
the Cape Town metropolitan region ( Cape Town Municipality (CTM) 
and Cape Metropolitan Council (CMC) areas of jurisdiction). 
5.2 DEFINITION OF TERMS 
Case Definition 
Any child under 14 years and residing in the above areas was 
designated 
a definite case if: 
N. meningitidis was isolated from the blood or cerebrospinal 
fluid (CSF) or 
clinical signs of meningitis or septicemia were accompanied 
by a haemorrhagic rash and Gram negative diplococci were 
detected in the CSF. 
and a probable case if 
clinical signs of meningitis or septicemia were accompanied 
by a haemorrhagic rash, but N. meningitidis was not 
isolated by culture or gram stain. 
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Cases were identified using a combination of the passive 
statutory notification system and an active surveillance system 
consisting of weekly scrutinising the admission registers at the 
City Hospital for Infectious Diseases. This hospital is the main 
referral centre for infectious disease in the region. 
Smoking Exposure 
A child was considered to have been exposed to cigarette smoke 
if a household member smoked. 
Household living density was measured in terms of a household 
crowding index. This crowding index is based on the work of 
Batson (where crowding is defined as the number of equivalent 
persons per number of sleeping rooms. A child 10 years or younger 
is considered half an equivalent person and a person older than 
10 years as an equivalent person) 96 • A crowding index of greater 
than 2.5 was taken as an indication of overcrowding . 
Type of dwelling was recorded as one of the following : brick 
house, apartment/flat, shack, tent, prefabricated building or 
other. 
Nutritional status was measured in terms of weight for age . The 
growth reference charts developed by the National Centre for 
Statistics and Centre for Disease Control (the 1976 NCHS charts) 
were used and the cut off point to determine nutritional status 
was the median minus 2 standard deviations . 
17 
Duration of breastfeeding was measured as a categorical variable. 
The following categories were used: 
not breastfed 
< 3 months 
? 3 < 6 months 
;;:. 6 < 12 months 
;::. 12 months 
Recent antibiotic use was defined as a history of any antibiotic 
use in the preceding month. 
Upper respiratory tract infection (URTI) was defined as a runny 
or stuffy nose in the preceding month. 
Contact with a case of meningitis was defined as a history of any 
contact with a person that had meningitis. Information was also 
collected on when the contact occurred. 
Selection of controls 
Controls were selected from the trauma wards at Red Cross War 
Memorial Childrens Hospital, the regional paediatric referral 
centre. Controls were under the age of 14 years and permanent 
residents in the area being studied ie the Cape Town Metropolitan 
region. Three controls were selected for each case, within a 3 
month period from ascertainment of the corresponding case. 
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5. 3 DATA COLLECTION 
Trained medical staff at City Hospital, by means of a pre-tested 
questionnaire (see appendix), elicited case exposure histories 
and other relevant information from the parents or guardians. 
These interviews were conducted in the wards. Patients that were 
detected by the surveillance system but had not been admitted to 
City Hospital were contacted at their homes by the CMC or CTM 
district nurse. The district nurse administered the same 
questionnaire to the parent or guardian. A trained interviewer 
administered the same questionnaire to the parent or guardian of 
the selected controls . 
A five percent random sub-sample was selected for repeatability 
testing of the measuring instrument . Different interviewers were 
used during the repeat interviews. 
5. 4 ETHICS 
Approval for the study was obtained from the Ethics Committee of 
the University of Cape Town. Informed consent was obtained from 
the parents or guardians of all children. All data sheets and 
completed questionnaires were kept under the strict supervision 
of the field coordinator. 
19 
5.5 ANALYSIS 
Analysis was done using SAS (version 6) and EPI INFO statistical 
software. The chi-squared test was used to test for significant 
d i fferences between categorical variables. For numerical 
variables either the t test or the Wilcoxon sum of ranks test was 
used to test for significant differences. The Breslow - Day test 
was used to assess the homogeneity of the odds ratios across 
strata. Multiple logistic regression was performed to determine 
the association between passive smoking and meningococcal disease 
after adjusting for confounders. Crude odds ratios, adjusted 
odds ratios and 95% confidence intervals (CI) are reported. 
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6. RESULTS 
Information was collected on 70 cases and 210 controls. There 
were 35 definite cases and 35 probable cases. All cases were 
analysed together. The interviewee was the parent for 91% of 
cases and 81% of controls. This difference was not significant 
(p=0.06) . The percentage agreement between initial and repeat 
interviews for the questions relating to: the number of people 
per household was 92%, the number of rooms was 83% and the number 
of smokers was 75%. 
UNIVARIATE RESULTS 
Socio - demographic data 
The median age of the cases was 27 months and that of the 
controls 60 months. This difference was significant 
(p = 0 . 0001). There was a male predominance amongst cases (64%) 
and controls (65%). There was no significant difference in 
residential distribution of the cases and controls. The majority 
of both cases and controls were from the Cape Flats area (35% and 
42% respectively). Although there were more cases (13%) than 
controls (5%) from the West Coast area, this difference was not 
significant (p=0.059). The majority of cases (66%) and controls 
(69%) lived in brick houses. 
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Smoking Exposure 
Data related to smoking exposure is summarized in tables 1, 2 and 
3 . Household exposure to cigarette smoke occurred among 78% of 
the cases and 74% of the controls. This difference was not 
significant (p = 0.50) However significantly more cases than 
controls came from homes with 2 or more smokers. The proportion 
of homes with 3 or more smokers per home was higher for cases 
than controls, although this difference was not significant. A 
higher proportion of cases than controls had main caregivers that 
smokers, but this difference was not significant. 
Table 1 Number of household smokers - univariate data 
Household Smokers Cases Controls 
Mean 1. 8 1.5 
Median 2.0 1.0 
Range 1 - 7 1 - 6 
p = 0.111 
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Table 2 Proportion of households with smokers 
Number of smokers % of Cases % of Controls 
{n = 68) {n = 210) 
none 22 26 
1 19 29 
2 29 23 
3 18 12 
4 9 7 
5 2 2 
6 0 1 
7 1 0 
Table 3 Smoking exposure 
Variable Cases Controls 
p OR 95% CI 
% % value 
Any 78 74 




~ 2 59 






~ 3 29 






House- 40 31 0






House- 18 11 0.





Main care 52 39 0.0




OR= odds ratio 
Heavy smokers : use of> 20 cigar
ettes per day 
Moderate smoking: use of> 10 ~ 2




Data relating to crowding is summarised in tables 4, 5, 6 and 8. 
Case homes had significantly more rooms than control homes. The 
number of occupants per household did not differ significantly. 
Overcrowding was a significant risk factor for meningococcal 
disease (Table 8) 
Table 4 Number of rooms per household 
Rooms per Cases Controls 
household 
Mean 3.1 3.9 
Median 3.0 4.0 
Range 1 - 6 1 - 8 
p = 0.0004 
Table 5 Occupants per household 
Occupants per Cases Controls 
household 
Mean 6.4 6.1 
Median 6.0 6.0 
Range 1 - 19 2 - 14 
p = 0.74 
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Table 6 Crowding index 
Crowding Index Cases Controls 
Mean 2.0 1. 5 
Median 1. 7 1. 3 
Range 0.6 - 8 0.4 - 8 
p = 0.0007 
26 
Duration of Breastfeeding 
Data is summarised in Tables 7 and 8 . Controls tend
ed to have 
been breastfed for longer periods than cases. Th
ere was a 
significant association between being breastfed for 
3 months or 
less (including not being breastfed) and meningococ
cal disease 
(Table 8). 
Table 7 Duration of breastfeeding 
Duration in months % of Cases % of Controls 
(n = 70) (n = 189) 
0 (not breastfed) 6 10 
< 3 41 15 
3- 3 < 6 20 29
 
3- 6 < 12 9 18
 
>, 12 24 28 
27 
Contact with a case of meningitis 
Significantly more cases than controls had a history of contact 
with a case of meningitis (Table 8). The median time of exposure 
to a case of meningitis was 6 months prior to the interview 
(range 1 to 36 months). 
Other Risk Factors 
As can be seen from Table 8 significant risk factors for 
meningococcal disease include: history of a recent URTI, history 
of contact with a case of meningitis, poor nutritional status, 
being breastfed for less than three months and living in 
overcrowded accommodation. 
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Table 8 Risk factors for meningococcal disease 
Variable Cases Controls p OR 95% CI 
% % value 
(n} (n} 
History of 59 45 0.043 1. 77 1.02-3.09 
previous URTI ( 4 0) ( 91) 
n = 273 
Attendance at 25 18 0.283 1. 53 0.65-3.59 
creche (13) (22) 
n = 175 
Contact with a 16 4 0.003 4.57 1.7-12.5 
case of ( 9) (8) 
meningitis 
n = 260 
recent 36 39 0.626 0.89 0.49-1.53 
antibiotic use (25) (78) 
n = 270 
nutritional 10 2.9 0.033 3.6 1.12-11.68 
status ( 6) ( 6) 
WAZ < - 2 
n=271 
breastfed for 47 25 0.001 2.69 1.45-5.01 
< 3 months (33) (4 7) 
(including not 
breastfed) 
n = 259 
CI > 2.5 29 12 0.002 2.83 1.46-5.49 
n=280 (20) (26) 
LEGEND 
WAZ= weight for age Z value 
CI crowding index 
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STRATIFIED ANALYSES 
The association between exposure to cigarette smoke and 
meningococcal disease was modified by the presence of an URTI. 
Results are summarised in the tables below. 
Table 9 Crude association between exposure to 2 or 
more smokers and meningococcal disease 
Exposure to? 2 smokers 







Odds Ratio= 1.8 95% CI 1.0 - 3.1 
Table 10 Association between exposure to 2 or more smokers 
and meningococcal disease among those with a 
history of a recent upper respiratory 
tract infection 
Cases (n) 
Exposure to~ 2 smokers 27 




Odds Ratio= 3.1 95% CI= 1.3 - 7.4 
Table 11 : Association between exposure to 2 or more smokers 
and meningococcal disease among those with no 
history of a recent upper respiratory 
tract infection 
Exposure to~ 2 smokers 








Breslow - Day test for homogeneity p = 0.024 
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The odds ratio in the presence of a history of a recent URTI 
was 3.1 compared to an odds of 0.8 if there was no history of a 
recent URTI. 
Table 12 Crude association between exposure to a main 
caregiver that smokes and meningococcal disease 
Cases (n) Controls (n) 
Main care giver smokes 35 
32 
82 
116 Main care giver does not smoke 
Odds Ratio= 1.7 95% CI= 0.9 - 3.1 
Table 13 Association between exposure to a main caregiver 
that smokes and meningococcal disease among those 
with a history of a recent upper respiratory 
tract infection 
Main care giver smokes 









Table 14 Association between exposure to a main caregiver 
that smokes and meningococcal disease among those 
with no history of a recent upper respiratory 
tract infection 






Main care giver does not smoke 60 
Odds Ratio= 1.0 95% CI 0.4 - 2.5 
Breslow - Day test for homogeneity p = 0.049 
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The odds ratio if the main caregiver smoked and there was recent 
exposure to a URTI was 3.1 and decreased to 1.0 in the absence 
of a recent URTI. 
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MULTIPLE LOGISTIC REGRESSION 
Two multiple logistic regression models were fitted. The first 
was f i tted to examine the association between the presence of 2 
or more household smokers and meningococcal disease. The 
fo llowing variables were included in the model overcrowding, 
nutritional status, age (as a categorical variable, with the 
overall median age used as a cut off point ie. ~ 48 months or 
> 48 months), breast feeding (as a categorical variable -
< 3 months (including not being breastfed) and ~ 3 months), 
recent URTI and the URTI interaction with 2 or more household 
s mokers. Contact with a case was excluded as a variable when 
logistic regression was performed as investigation into the time 
and type of contact as well as into the hospital records of some 
of the named primary cases, done only after the study was 
completed, showed that contact could not be reliably ascertained 
on h istory alone. Stepwise, forward and backward regression all 
yielded the same final model. The results are summarised in 
Table 15 . The presence of 2 or more household smokers was no 
longer associated with meningococcal disease. 
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Table 15 Results of logistic regression model
 fitted to examine 
the association between the presence of 2 or more 
household smokers and meningococcal disease 
Variable Odds Ratio 95% CI 
2 or more smokers 0.6 0.25 - 1.48 
in household 
breastfed 2.4 1. 26 - 4.43 
overcrowding 2.3 1. 00 - 5.30 
nutritional status 2.1 0.51 - 8.41 
age 2.3 1. 25 - 4.36 
URTI 0.7 0.30 - 1. 76 
interaction :URTI 5.0 1.44 - 17.31 
and smoke exposure 
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The second model was fitted to examine the association betw
een 
exposure to a main caregiver that smokes and meningoco
ccal 
disease. The following variables were included in the mod
el 
overcrowding, nutritional status, age (as a categorical varia
ble 
- ~ 48 months or > 48 months), breast feeding ( as a categor
ical 
variable - < 3 months (including not being breastfed and
~ 3 
months), recent URTI and the URTI interaction with 2 or 
more 
household smokers. Contact with a case was excluded as a varia
ble 
when logistic regression was performed for reasons lis
ted 
earlier. Stepwise, forward and backward regression all yiel
ded 
the same final model. The results are summarised in Table 
16. 
Exposure to a main caregiver that smoked was still not a 
risk 
factor for meningococcal disease. 
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Table 16 Results of logistic regression model fitted 
to examine 
the association between exposure to a main caregiver 
that smokes and meningococcal disease 
Variable Odds Ratio 95% CI 
main care giver 0.9 0.38 - 2.25 
smokes 
breastfed 2.2 1.17 - 4.19 
overcrowding 2.2 0.94 - 5.07 
nutritional status 1.1 0.25 - 5.09 
age 2.2 1.17 - 4.12 
URTI 1. 0 0.43 - 2.32 
interaction :URTI 3.5 1.01 - 12.01 
and smoke exposure 
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7. DISCUSSION 
7 . 1 Demography 
The median age of the cases was 27 months. Seventy one percent 
of cases were under the age of 5 years. These findings are 
consistent with the age profile of cases of meningococcal 
infection in South Africa2 - 1 • Children that were 4 years old and 
younger were twice as likely to develop meningococcal disease 
compared to those older than 4 years, confirming previous 
findings that the risk of meningococcal infection increases with 
decreasing age64 • 
7.2 Passive Smoking 
Passive smoking is known to be associated with an increased risk 
of respiratory disease in young children47 - 51 • Cigarette smoke 
interferes with ciliary action, increases mucus production and 
decreases macrophage production, thereby decreasing the body's 
local defence against potential pathogens 97 • Previous studies 
have found as association between passive smoking and 
meningococcal disease35 ' 36 ' 39 ' 46 • More cases than controls had main 
caregivers that smoked (Table 3) , however this difference was not 
statistically significant. Although significantly more cases than 
controls came from homes with 2 or more smokers, after adjusting 
for confounders exposure to 2 or more household smokers was no 
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longer a significantly associated with meningococcal disease. The 
prevalence of household smoking was high for both cases and 
controls. Lack of statistical power may therefore explain these 
findings, rather than a true lack of effect. 
7.3 Upper Respiratory Tract Infection 
Previous studies have implicated viral URTI as a co-factor and 
an association between influenza type A and meningococcal disease 
has been documented33 • 34 • The main force of passive smoking as a 
risk factor for meningococal disease apperared to be in the 
presence of a recent upper respiratory tract infection. A 
possible explanation is that a recent URTI could denude the 
mucosa and, in the presence of already decreased local defence 
due to the action of cigarette smoke on the mucosa, increase the 
chances even further of invasion by the meningococcal organism. 
Further studies are needed to examine the association between 




Pr olonged breast feeding has been found to protect infants 
a gainst respiratory disease in general 98 • 99 • This is thought to be 
due to the transmission of specific human immunoglobulins in 
b r east milk that improves the immunological defence mechanism of 
i n fants 1 00 • A study in the Gambia has suggested that breast 
f eeding may protect infants against meningococcal disease 44 • In 
ge neral controls were breastfed for longer periods than cases 
(Table 7) and breastfeeding was associated with meningococcal 
d i sease (Tables 15 and 16) , confirming the postulate of the 
Gambian study. This study adds to the importance of encouraging 
publi c health measures that promote breastfeeding. 
7.5 Contact with a Case 
An increased risk of meningococcal disease has been reported 
f ol lowing close contact with a case 39 • 45 • An attempt was made 
dur ing the interview with the parent or guardian to determine 
whether there had been any contact with a case of meningococcal 
meningitis. Further investigation into the time and type of 
c ontact as well as into the hospital records of some of the named 
p r imary cases, done only after the study was completed, showed 
however that contact could not be reliably ascertained on history 
a lone. Contact with a case was therefore excluded as a variable 
f rom the multiple logistic regression analysis. Future studies 
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need to obtain definitive evidence of contact with a true case 
of meningococcal disease. 
7.6 Overcrowding 
Overcrowding has been associated with ill health1 0 1 • The mean 
crowding index was 2.0 for cases and 1.5 for controls (Table 6). 
The results of this study support the findings of other studies 
that overcrowding is associated with meningococcal disease39 • 40 • 
7.7 Nutritional Status 
Malnutrition and infection are closely linked102 • Children that 
are malnourished are often more prone to certain infections than 
those that are well nourished. Ten percent of cases and three 
percent of controls had a low weight for their age (Table 8). 
However after controlling for confounders, nutritional status was 
not associated with meningococcal disease (Tables 15 and 16). 
This is in keeping with the findings of an earlier study done in 
Cape Town in which the presentation of 113 children that were 
admitted, between 1976 and 1982, to Red Cross Hospital with 
meningococcal infection was described, and children with 
malnutrition were found to be no different in their presentation, 
morbidity or mortality. 
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7.8 Data Quality, Limitations and Bias 
The selection of an appropriate comparison group is perhaps the 
most critical issue in the design of a case-control study. A 
crucial requirement is that the controls be comparable to the 
source population of the cases1 0 3 • Cases were selected from the 
City Hospital for Infectious Diseases and controls from the 
trauma wards at Red Cross War Memorial Children's Hospital. 
Hospital controls were selected because of their logistic and 
financial convenience. Both of the hospitals used are referral 
centres for the Cape Metropole, thus the principle of 
comparability of study base is unlikely to have been violated. 
Controls from the trauma wards were selected so as to avoid any 
Berksons bias104 • Controls were significantly older than the 
cases. However this difference was controlled for in the multiple 
logistic regression. 
Information about exposure status and other variables of interest 
were obtained by interviews. Interviewers were blinded to the 
hypothesis to minimize the possibility of observation bias. Risk 
factors for meningococcal disease are not widely known and since 
both cases and controls were in hospital it is unlikely that 
recall bias occurred. 
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Smoking exposure was measured using a a questionnaire. It is 
possible that misclassification of smoking exposure status could 
have occurred. If this did occur it is likely to have been a 
random misclassification. In general random misclassification 
reduces the chances of observing any difference between the 
exposed and unexposed105 • The combination of a questionnaire about 
exposure to passive smoking and the use of biological markers eg. 
urinary cotinine, would perhaps of fer the best method for 
accurate assessment of exposure to passive smoking106 • 
7.9 Validity 
Smoking exposure could have been validated by measuring urinary 
cotinine levels in the children, however this was not 
logistically or financially possible. 
7.10 Reliability 
An attempt was made to assess reliability by repeating selected 
questions in a randomly selected five percent sub sample. The 
questions repeated all had answers that were numerical variables 
and reliability was assessed by measuring the percentage of 
agreement between initial and repeat interviews. The percentage 
of agreement was acceptable. 
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8. RECOMMENDATIONS 
8.1 Sample Size 
The prevalence of passive smoking among cases and controls was 
much higher than anticipated. Future studies will need a much 
larger sample size to detect an association between passive 
smoking and meningococcal disease. 
8.2 Measurement 
Exposure to cigarette smoke was ascertained from questionnaires 
alone. Future studies should consider measuring urinary cotinine 
levels as this would give a more accurate assessment of exposure 
to cigarette smoke. 
8.3 Public Health Policies 
8.3.1 Vaccination 
This study identified children under the age of 4 years as being 
at a much higher risk of developing meningococcal disease. When 
an effective vaccine becomes available, children under the age 
of 4 years should be targeted. 
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8.3.2 Passive Smoking 
The extremely high prevalence of smoking is disturbing. Public 
health efforts that lower the prevalence of cigarette smoking by 
parents of young children, may reduce the incidence of 
meningococcal disease and should be encouraged. 
8.3.3 Breastfeeding 
Promotion of breastfeeding could have an impact on the incidence 
of meningococcal disease. 
9. CONCLUSION 
This is the first case-control study examining risk factors for 
meningococcal disease in South Africa and the high prevalence 
area of Cape Town in particular. The study provides further 
evidence for the promotion of breast feeding and reduction of 
overcrowding as important public health measures. Children under 
the age of four have also been identified as an important target 
group, should an effective vaccine become available. Passive 
smoking was found to be a risk factor for meningococcal disease 
in the presence of a recent URTI. This finding adds weight to the 
evidence that passive smoking is harmful to human health. Passive 
smoking is a risk factor that should be given greater attention 
in further studies on meningococcal disease. 
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Interviewers Surname & initials 
Person being interviewed : 
Surname and initials 
Relation to patient 
(eg mother, father, guardian) 
Date of Interview (dd/mm/yy) 
Name of Hospital 
Hospital number 










Was this patient referred from another hospital 
Yesa 
~ 
If Yes Which hospital 
(Mo NO II] 
7 I J 
•o o 
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QUESTIONNAIRE 
Good morning/afternoon Hr/s . I am doing research for the 
community health and paediatric departments. I would like to ask you a 
few simple questions about this patient. Anything you tell us will remain 
totally confidential. 





Type of Dwelling 











~ow many rooms are there in the patient's household? 
(excluding ' bathrooms and toilets) 
~ow many of these rooms are used for sleeping? 
!ow many people live in this household for at least 4 days 
of the week (including patient) :-
Total number 
Number of people age 10 years or less 
Number of people older than 10 years 
ow long has this child lived in Cape Town ~Yrs~ Mnths 
oes the child attend primary/high school 






























:5~ I I I I I 
;,~ D 
Does the child attend a 
creche/preschool/daymother/playcentre? 
Yes 
D ~ If YES 
How many children are in the class/centre 
Less 5 children 
More than 5 children 
How long does this child spend there 
Half a day 
A full day 
Don't know 
Does the daymother/teacher smoke whilst 







Yes D No D Don't Know D , 
Who is the main care giver i.e(spends the most time with child) 
( Relation to child) 
Does this person smoke? 
Yesa Don't Knowa 
PAST CLINICAL HISTORY 
How long was this child breastfed for? 
Less than 3 months D More than 12 mnthsa 
From 3 to 6 months D Not Breastfed D 
From 6 to 12 month D Don't Know D 
Has this child had a runny nose, cold, 
or flu in the past l month 







Has the child had any_antibiotics in 
the past 1 month 
Yesa Noa Don't Knowa 
Has this child had any operations in the last year? 
Yes D No (D] 
~IF YES 
Don't Know a 
Was this operation a tonsillectomy or an adenoidectomy 
YESD Don't Knowa 
Has this child been in contact with anybody that 
has had meningitis 
Yesa~ Noa Don't Knowa 
IF YES 
State how long ago this was (in months) 
State who this person was (relationship to child) 
Did this person kiss the child? 
,;esa No a Don't Know a 
PRESENT CLINICAL DETAILS 
(if necessary confirm with doctor) 
Weight in kilograms to one decimal place 
aa 
Was N.Meningitidis isolated from the blood or CSF 
Yesa Noa 
Were Gram negative diplococci detected in the CSF 
Yeso 
Haemorrhagic rash 
. Ever Presento 














Fill in for all adults & children (excluding patient) 
living in the household for at least four days of the week 
1 2 3 4 5 6 
1. Initials of person 
2.Relation to ch{ld (please tick) 
mother 
father 




3.Age of person in years --
4.Has this person slept in the same room as the patient for 




5.Does he/she smoke cigarettes .. • . -
. Yes 
No 
' Don't -Know 
IF HE/SHE SMOKES CIGARETTES 
·-- - ,-, .. 
6.How many cigarettes does he/she smoke per day 
less than 5 
from 5 to 10 , ·. 
from 10 to 20 
than 20 
.. . . - ., more 
don't know . . 
7.How long has he/she been smoking for .. 
. .. less than 1 year 
from 1 to 5 years ·- . 




CONTINUED • • • 
Fill in for all adults & children (excluding patient) living in the 
patient's household for at least four days of the week 
7 8 9 10 11 12 
!.Initials of person 







3.Age of person in years 
4.Has this person slept in the same room as the patient for 








IF HE/SHE SMOKES CIGARETTES 
6.How many cigarettes does he/she smoke per day 
less than 5 
from 5 to 10 
from 10 to 20 
more than 20 
don't know 
7.How long has he/she been smoking for 
less than 1 year 
from 1 to 5 years 
more than 5 years 
don't know 
6 
